Disease · MONDO_0100347
Trials17
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.
1 to 17 of 17
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03223428 | Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO | 223 | 2024-07-15 | Carcinoid Syndrome | TELOTRISTAT ETHYL | Its record names the disease | ClinicalTrials.gov | |
| NCT01677910 | TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) | Phase 3 | 135 | 2017-09-18 | Carcinoid Syndrome | TELOTRISTAT | Its record names the disease | ClinicalTrials.gov |
| NCT00774930 | An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome | Phase 3 | 115 | 2016-02-09 | Carcinoid Syndrome | LANREOTIDE | Its record names the disease | ClinicalTrials.gov |
| NCT04810091 | Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor | Phase 3 | 79 | 2026-02-05 | Locally Advanced Neuroendocrine Neoplasm, Metastatic Neuroendocrine Neoplasm | TELOTRISTAT ETHYL | Its record names the disease | ClinicalTrials.gov |
| NCT05361668 | Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome | Phase 2 | 36 | 2025-10-31 | Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum, Carcinoid Tumor of Cecum, Carcinoid Syndrome Diarrhea, Carcinoid Intestine Tumor, Carcinoid Tumor of Liver, Carcinoid Tumor of Pancreas | PALTUSOTINE | Its record names the disease | ClinicalTrials.gov |
| NCT00853047 | Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy | Phase 2 | 23 | 2018-12-26 | Carcinoid Syndrome | OCTREOTIDE, TELOTRISTAT | Its record names the disease | ClinicalTrials.gov |
| NCT01104415 | Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome | Phase 2 | 15 | 2018-04-06 | Carcinoid Syndrome | TELOTRISTAT | Its record names the disease | ClinicalTrials.gov |
| NCT01018953 | Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome | Phase 2 | 8 | 2015-09-07 | Carcinoid Syndrome | ONZIGOLIDE | Its record names the disease | ClinicalTrials.gov |
| NCT01886287 | P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome | Phase 2 | 2 | 2015-01-12 | Neuroendocrine Carcinoma | OCTREOTIDE | Its record names the disease | ClinicalTrials.gov |
| NCT07087054 | Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen | Phase 3 | 141 | Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum, Carcinoid Tumor of Cecum, Carcinoid Tumor of Liver, Carcinoid Tumor of Pancreas, Carcinoid Syndrome Diarrhea, Carcinoid Intestine Tumor | PALTUSOTINE | Its record names the disease | ClinicalTrials.gov | |
| NCT04039516 | Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy | Phase 2 | 20 | Carcinoid Heart Disease, Carcinoid Syndrome, Carcinoid Tumor | LUTETIUM OXODOTREOTIDE LU-177 | Its record names the disease | ClinicalTrials.gov | |
| NCT00884715 | Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome | Phase 1/2 | 10 | Carcinoid Syndrome | OCTREOTIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT00092287 | Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome | Phase 3 | 4 | Malignant Carcinoid Syndrome | LANREOTIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT01172717 | Study of Panitumumab in the Treatment of Carcinoid Syndrome | Phase 2 | 0 | Carcinoid Syndrome | PANITUMUMAB | Its record names the disease | ClinicalTrials.gov | |
| NCT04065165 | Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome | Phase 3 | 0 | Small Intestinal NET, Carcinoid Heart Disease | LANREOTIDE, TELOTRISTAT ETHYL | Its record names the disease | ClinicalTrials.gov | |
| NCT04713202 | Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl | Phase 2 | 0 | Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea | TELOTRISTAT ETHYL | Its record names the disease | ClinicalTrials.gov | |
| NCT04776876 | Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome | Phase 2 | 0 | Advanced Neuroendocrine Neoplasm, Carcinoid Syndrome | RETIFANLIMAB, TELOTRISTAT ETHYL | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0100347/trials